Varicella Vaccine Suppliers & Bulk Manufacturers
Available Forms: Lyophilized powder, Pre-filled syringes
Available Strengths: 0.5 mL
Reference Brands: Varivax, VariZIG(US)
Category: Vaccines
Varicella vaccine stimulates immunity by introducing weakened varicella-zoster virus, enabling the body to produce protective antibodies. It prevents chickenpox, reduces disease severity, and lowers transmission. Benefits include lifelong immunity, decreased outbreaks, and protection of vulnerable populations, supporting global efforts to eliminate varicella-related complications. Varicella Vaccine is available in Lyophilized powder, Pre-filled syringes and strengths such as 0.5 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Varicella Vaccine is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Varicella Vaccine can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description: Varicella vaccines are approved in both the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality compliant with GMP and IVDR standards. In the US, FDA approval requires extensive clinical data, while in the EU, CE marking certifies conformity with in vitro diagnostic and vaccine regulations. These products undergo validation, stability testing, and quality audits, with comprehensive documentation including safety profiles, clinical trial results, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective varicella vaccination, essential for preventing chickenpox and related complications worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Respiratory Syncytial Virus Mrna Vaccine
Strength:
0.5 mL
Form: injection (prefilled syringe)
Reference Brands: mRESVIA (USA/EU)
View Details
Inactivated Vaccines
Strength:
Dose and concentration depend on formulations
Form: Injectable suspension (IM administration), Lyophilized powder for reconstitution
Reference Brands: Sinovac Coronavac. Covaxin(EU)
View Details
Viral Vector Vaccines
Strength:
0.5 mL
Form: Intramuscular injectable suspension (IM)
Reference Brands: US: Johnson & Johnson’s Janssen (Jcovden)
View Details
Mrna-Based Vaccines
Strength:
30 µg and 100 µg
Form: Injectable suspension
Reference Brands: Comirnaty, Spikevax(US)
View DetailsQuick Response Guaranteed | Verified Suppliers
